Diseases & Disorders
(G034)
990 on File
INTL SOCIETY OF CARDIOVASCULAR DISEASE EPIDEMIOLOGY & PREVENTION
Financial strength (30%)
63/100
Reliability (20%)
55/100
Effectiveness (25%)
51/100
Impact (25%)
No data yet
CharityAI™ Score
Not yet evaluated
Financial Overview — FY 2024
$92K
Total Revenue
$90K
Total Expenses
$278K
Net Assets
N/A
Employees
Revenue Sources
Expense Breakdown
Program Expense Ratio
97.2%
Fundraising Efficiency
N/A
Operating Reserve
37.05x
Liability-to-Asset
0.0%
Revenue Diversification
97.3%
Compared with Peers
FY 2024
Compared with 1,426 similar organizations
(United States, Diseases & Disorders, under $100K in expenses), FY 2024.
This organization
Middle half of peers (P25–P75)
Peer median
| Ratio | This org | Peer median | Position (P10 → P90) | |
|---|---|---|---|---|
|
Program expense ratio
Program expenses / total expenses
· higher is better
|
97.2% | 80.0% |
P10P90
|
Above median |
|
Operating reserve
Months of expenses covered by net assets
· higher is better
|
37.1 mo | 23.3 mo |
P10P90
|
Above median |
|
Liabilities to assets
Total liabilities / total assets
· lower is better
|
0.0% | 0.0% |
P10P90
|
Top quarter |
|
Revenue concentration
Share of revenue from the largest source
· lower is better
|
97.3% | 99.5% |
P10P90
|
Above median |
|
Revenue growth
Year over year revenue growth
|
38.6% | -0.4% |
P10P90
|
|
|
Expense growth
Year over year expense growth
|
57.5% | 0.4% |
P10P90
|
|
|
Surplus margin
Surplus as a share of revenue
|
1.7% | 8.6% |
P10P90
|
Financial History
| Year | Revenue | Expenses | Net Assets | Program % | Staff |
|---|---|---|---|---|---|
| 2024 | $92K | $90K | $278K | 97.2% | — |
| 2023 | $66K | $57K | $277K | 92.2% | — |
| 2022 | $18K | $91K | $268K | 99.1% | — |
| 2021 | $18K | $14K | $342K | 82.7% | — |
Donor Reviews
Write a ReviewNo reviews yet
Be the first to share your experience with this organization.